Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 17 studies | 23% ± 5% | |
| astrocyte | 13 studies | 26% ± 9% | |
| basal cell | 12 studies | 28% ± 11% | |
| capillary endothelial cell | 8 studies | 22% ± 4% | |
| endothelial cell of artery | 7 studies | 23% ± 7% | |
| epithelial cell | 7 studies | 37% ± 14% | |
| secretory cell | 7 studies | 29% ± 11% | |
| squamous epithelial cell | 4 studies | 35% ± 23% | |
| endothelial cell of vascular tree | 4 studies | 20% ± 4% | |
| glomerular endothelial cell | 3 studies | 20% ± 2% | |
| ciliated cell | 3 studies | 28% ± 5% | |
| luminal cell of prostate epithelium | 3 studies | 22% ± 6% | |
| GABAergic neuron | 3 studies | 27% ± 9% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 8377.46 | 1445 / 1445 | 100% | 138.90 | 183 / 183 |
| brain | 100% | 8372.50 | 2633 / 2642 | 100% | 247.37 | 704 / 705 |
| prostate | 100% | 6475.09 | 245 / 245 | 99% | 68.75 | 499 / 502 |
| uterus | 100% | 6533.38 | 170 / 170 | 98% | 101.80 | 452 / 459 |
| breast | 100% | 5957.59 | 459 / 459 | 98% | 50.52 | 1100 / 1118 |
| intestine | 100% | 5160.83 | 966 / 966 | 98% | 60.98 | 518 / 527 |
| lung | 100% | 9168.51 | 578 / 578 | 98% | 78.77 | 1128 / 1155 |
| stomach | 100% | 4125.75 | 359 / 359 | 97% | 56.60 | 278 / 286 |
| thymus | 100% | 5821.24 | 652 / 653 | 97% | 65.49 | 587 / 605 |
| kidney | 100% | 3336.56 | 89 / 89 | 96% | 52.48 | 869 / 901 |
| skin | 100% | 6389.43 | 1808 / 1809 | 96% | 51.02 | 452 / 472 |
| bladder | 100% | 6392.76 | 21 / 21 | 95% | 63.78 | 481 / 504 |
| liver | 100% | 3178.67 | 225 / 226 | 94% | 42.36 | 381 / 406 |
| pancreas | 88% | 1932.60 | 290 / 328 | 99% | 116.71 | 176 / 178 |
| adrenal gland | 100% | 3464.29 | 257 / 258 | 87% | 38.12 | 201 / 230 |
| ovary | 100% | 3795.47 | 180 / 180 | 86% | 32.43 | 368 / 430 |
| blood vessel | 100% | 12763.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3342.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 121.02 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.94 | 1 / 1 |
| adipose | 100% | 6449.37 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 3695.55 | 842 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 38.90 | 77 / 80 |
| muscle | 65% | 1364.21 | 524 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 16.81 | 18 / 29 |
| peripheral blood | 37% | 656.54 | 344 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0098656 | Biological process | monoatomic anion transmembrane transport |
| GO_0015810 | Biological process | aspartate transmembrane transport |
| GO_0045663 | Biological process | positive regulation of myoblast differentiation |
| GO_0015734 | Biological process | taurine transmembrane transport |
| GO_0002329 | Biological process | pre-B cell differentiation |
| GO_0006884 | Biological process | cell volume homeostasis |
| GO_0006970 | Biological process | response to osmotic stress |
| GO_0001678 | Biological process | intracellular glucose homeostasis |
| GO_0032024 | Biological process | positive regulation of insulin secretion |
| GO_0140361 | Biological process | cyclic-GMP-AMP transmembrane import across plasma membrane |
| GO_0006820 | Biological process | monoatomic anion transport |
| GO_1902476 | Biological process | chloride transmembrane transport |
| GO_0034214 | Biological process | protein hexamerization |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0034702 | Cellular component | monoatomic ion channel complex |
| GO_0009986 | Cellular component | cell surface |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0005225 | Molecular function | volume-sensitive anion channel activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005253 | Molecular function | monoatomic anion channel activity |
| GO_0140360 | Molecular function | cyclic-GMP-AMP transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LRRC8A |
| Protein name | Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (HsLRRC8A) (Swelling protein 1) |
| Synonyms | UNQ221/PRO247 SWELL1 KIAA1437 LRRC8 |
| Description | FUNCTION: Essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes . The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine . Mediates efflux of amino acids, such as aspartate and glutamate, in response to osmotic stress . LRRC8A and LRRC8D are required for the uptake of the drug cisplatin . In complex with LRRC8C or LRRC8E, acts as a transporter of immunoreactive cyclic dinucleotide GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol: mediates both import and export of 2'-3'-cGAMP, thereby promoting transfer of 2'-3'-cGAMP to bystander cells . In contrast, complexes containing LRRC8D inhibit transport of 2'-3'-cGAMP . Required for in vivo channel activity, together with at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition . Can form functional channels by itself (in vitro) . Involved in B-cell development: required for the pro-B cell to pre-B cell transition . Also required for T-cell development (By similarity). Required for myoblast differentiation: VRAC activity promotes membrane hyperpolarization and regulates insulin-stimulated glucose metabolism and oxygen consumption (By similarity). Also acts as a regulator of glucose-sensing in pancreatic beta cells: VRAC currents, generated in response to hypotonicity- or glucose-induced beta cell swelling, depolarize cells, thereby causing electrical excitation, leading to increase glucose sensitivity and insulin secretion . Also plays a role in lysosome homeostasis by forming functional lysosomal VRAC channels in response to low cytoplasmic ionic strength condition: lysosomal VRAC channels are necessary for the formation of large lysosome-derived vacuoles, which store and then expel excess water to maintain cytosolic water homeostasis . . |
| Accessions | ENST00000259324.5 Q8IWT6 ENST00000372599.7 ENST00000372600.9 |